·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÀÇ·áºÐÀïÁ¶Á¤¿ø »óÀÓÁ¶Á¤À§¿øÈ¸¿¡ ÀÓÁÖÇö º¯È£»ç ±â»çÀÔ·Â : 14.08.18 15:50:16 0 °¡ ÇÃÄ£Ãß°¡ °æºÏ´ë ¹ýÇÐÀü¹®´ëÇпø °âÀӺα³¼ö µî ¿ªÀÓ Çѱ¹ÀÇ·áºÐÀïÁ¶Á¤ÁßÀç¿ø »óÀÓÁ¶Á¤À§¿øÀ¸·Î ÀÓÁÖÇö º¯È£»ç°¡ 18ÀÏ ÀÓ¿ëµÆ´Ù. ÀÓ »óÀÓÁ¶Á¤À§¿øÀº ¼¿ï´ëÇб³ ¹ý´ë ´ëÇпø(¼®»ç) ¹× °æºÏ´ëÇб³ ÀÇ´ë ´ëÇпø(¼®»ç ¹× ¹Ú»ç)À» Á¹¾÷Çß´Ù. ¶Ç ¹Ì ÇϹöµå´ëÇб³ º¸°Ç´ëÇпø¿¡¼ ¹æ¹®ÇÐÀÚ·Î ¿¬±¸Çϱ⵵ Çß´Ù. °æºÏ´ë ¹ýÇÐÀü¹®´ëÇпø °âÀӺα³¼ö, °æºÏ´ë ÀÇÇÐÀü¹®´ëÇпø ¿Ü·¡±³¼ö, ´ë±¸Áö¹æ¹ý¿ø ¹Î»çÁ¶Á¤À§¿øÀ» ¿ªÀÓÇß´Ù. X AD ´ºº£ÀÎ ¾à±¹ ÀλçÀ̵å À̺¥Æ®Âü¿© ¡æ ÃÖÀºÅà ±âÀÚ(etchoi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °³¹ß±âȹÆÀ BD °æ·Â ä¿ë ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â ¾È¼º/Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â RA/PV °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â °Ç±â½Ä»ç¾÷ÆÀ ¸¶ÄÉÆÃ, ¿µ¾÷, °³¹ß ºÎ¹®º° ¸ðÁý ¹Ù·Î°¡±â [°³¹ß¸ÞµðÄú»ºÎ] 2025³â 7¿ù ¾à»çÆÀ Á¤±ÔÁ÷ °æ·Â»ç¿ø ä¿ë°ø°í ¹Ù·Î°¡±â õ¿¬¹°ÀǾ࿬±¸ÆÀ(Á¦Á¦¿¬±¸) °æ·ÂÁ÷¿ø ¸ðÁý ¹Ù·Î°¡±â 2025³â Á¦2Â÷ ±¹¹Î°Ç°º¸Çè°ø´Ü Àü¹®ÀηÂ(¾à»ç) ä¿ë ¹Ù·Î°¡±â Á¦¾à¸¶ÄÉÆÃÆÀ ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â 2025³â Çѹ̱׷ì 7¿ù ¼ö½Ãä¿ë [°¢ ºÎ¹®º°] ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Sr. Market Access Specialist / Product Manager (Oncology) ä¿ë ¹Ù·Î°¡±â Á¦Á¶/ǰÁú°ü¸®¾à»ç ¸ðÁý(°æ·Â¹«°ü) ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & ±×¿Ü RA °æ·ÂÁ÷ Æ÷Áö¼Ç ¹Ù·Î°¡±â [»ï¿À±×·ì] ¿ø·áÀǾàǰ ¿µ¾÷/¸¶ÄÉÆÃ ´ã´ç(°æ·Â) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÇ·áºÐÀïÁ¶Á¤¿ø »óÀÓÁ¶Á¤À§¿øÈ¸¿¡ ÀÓÁÖÇö º¯È£»ç URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀÇ·áºÐÀïÁ¶Á¤¿ø »óÀÓÁ¶Á¤À§¿øÈ¸¿¡ ÀÓÁÖÇö º¯È£»ç ±â»çÀÔ·Â : 14.08.18 15:50:16 0 °¡ ÇÃÄ£Ãß°¡ °æºÏ´ë ¹ýÇÐÀü¹®´ëÇпø °âÀӺα³¼ö µî ¿ªÀÓ Çѱ¹ÀÇ·áºÐÀïÁ¶Á¤ÁßÀç¿ø »óÀÓÁ¶Á¤À§¿øÀ¸·Î ÀÓÁÖÇö º¯È£»ç°¡ 18ÀÏ ÀÓ¿ëµÆ´Ù. ÀÓ »óÀÓÁ¶Á¤À§¿øÀº ¼¿ï´ëÇб³ ¹ý´ë ´ëÇпø(¼®»ç) ¹× °æºÏ´ëÇб³ ÀÇ´ë ´ëÇпø(¼®»ç ¹× ¹Ú»ç)À» Á¹¾÷Çß´Ù. ¶Ç ¹Ì ÇϹöµå´ëÇб³ º¸°Ç´ëÇпø¿¡¼ ¹æ¹®ÇÐÀÚ·Î ¿¬±¸Çϱ⵵ Çß´Ù. °æºÏ´ë ¹ýÇÐÀü¹®´ëÇпø °âÀӺα³¼ö, °æºÏ´ë ÀÇÇÐÀü¹®´ëÇпø ¿Ü·¡±³¼ö, ´ë±¸Áö¹æ¹ý¿ø ¹Î»çÁ¶Á¤À§¿øÀ» ¿ªÀÓÇß´Ù. X AD ´ºº£ÀÎ ¾à±¹ ÀλçÀ̵å À̺¥Æ®Âü¿© ¡æ ÃÖÀºÅà ±âÀÚ(etchoi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °³¹ß±âȹÆÀ BD °æ·Â ä¿ë ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â ¾È¼º/Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â RA/PV °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â °Ç±â½Ä»ç¾÷ÆÀ ¸¶ÄÉÆÃ, ¿µ¾÷, °³¹ß ºÎ¹®º° ¸ðÁý ¹Ù·Î°¡±â [°³¹ß¸ÞµðÄú»ºÎ] 2025³â 7¿ù ¾à»çÆÀ Á¤±ÔÁ÷ °æ·Â»ç¿ø ä¿ë°ø°í ¹Ù·Î°¡±â õ¿¬¹°ÀǾ࿬±¸ÆÀ(Á¦Á¦¿¬±¸) °æ·ÂÁ÷¿ø ¸ðÁý ¹Ù·Î°¡±â 2025³â Á¦2Â÷ ±¹¹Î°Ç°º¸Çè°ø´Ü Àü¹®ÀηÂ(¾à»ç) ä¿ë ¹Ù·Î°¡±â Á¦¾à¸¶ÄÉÆÃÆÀ ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â 2025³â Çѹ̱׷ì 7¿ù ¼ö½Ãä¿ë [°¢ ºÎ¹®º°] ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Sr. Market Access Specialist / Product Manager (Oncology) ä¿ë ¹Ù·Î°¡±â Á¦Á¶/ǰÁú°ü¸®¾à»ç ¸ðÁý(°æ·Â¹«°ü) ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & ±×¿Ü RA °æ·ÂÁ÷ Æ÷Áö¼Ç ¹Ù·Î°¡±â [»ï¿À±×·ì] ¿ø·áÀǾàǰ ¿µ¾÷/¸¶ÄÉÆÃ ´ã´ç(°æ·Â) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÇ·áºÐÀïÁ¶Á¤¿ø »óÀÓÁ¶Á¤À§¿øÈ¸¿¡ ÀÓÁÖÇö º¯È£»ç URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀÇ·áºÐÀïÁ¶Á¤¿ø »óÀÓÁ¶Á¤À§¿øÈ¸¿¡ ÀÓÁÖÇö º¯È£»ç ±â»çÀÔ·Â : 14.08.18 15:50:16 0 °¡ ÇÃÄ£Ãß°¡ °æºÏ´ë ¹ýÇÐÀü¹®´ëÇпø °âÀӺα³¼ö µî ¿ªÀÓ Çѱ¹ÀÇ·áºÐÀïÁ¶Á¤ÁßÀç¿ø »óÀÓÁ¶Á¤À§¿øÀ¸·Î ÀÓÁÖÇö º¯È£»ç°¡ 18ÀÏ ÀÓ¿ëµÆ´Ù. ÀÓ »óÀÓÁ¶Á¤À§¿øÀº ¼¿ï´ëÇб³ ¹ý´ë ´ëÇпø(¼®»ç) ¹× °æºÏ´ëÇб³ ÀÇ´ë ´ëÇпø(¼®»ç ¹× ¹Ú»ç)À» Á¹¾÷Çß´Ù. ¶Ç ¹Ì ÇϹöµå´ëÇб³ º¸°Ç´ëÇпø¿¡¼ ¹æ¹®ÇÐÀÚ·Î ¿¬±¸Çϱ⵵ Çß´Ù. °æºÏ´ë ¹ýÇÐÀü¹®´ëÇпø °âÀӺα³¼ö, °æºÏ´ë ÀÇÇÐÀü¹®´ëÇпø ¿Ü·¡±³¼ö, ´ë±¸Áö¹æ¹ý¿ø ¹Î»çÁ¶Á¤À§¿øÀ» ¿ªÀÓÇß´Ù. X AD ´ºº£ÀÎ ¾à±¹ ÀλçÀ̵å À̺¥Æ®Âü¿© ¡æ ÃÖÀºÅà ±âÀÚ(etchoi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÇ·áºÐÀïÁ¶Á¤¿ø »óÀÓÁ¶Á¤À§¿øÈ¸¿¡ ÀÓÁÖÇö º¯È£»ç URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö